386 results on '"Lu, Liangjing"'
Search Results
2. Immune profile alterations of systemic lupus erythematosus patients with infections
3. Identification of a Novel Nonsense Mutation in NFKB1 Causing Common Variable Immunodeficiency with Decreased Tfh Cells
4. The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
5. A biomimetic adipocyte mesenchymal stem cell membrane-encapsulated drug delivery system for the treatment of rheumatoid arthritis
6. Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling
7. Clinical phenotypes and prognoses of microscopic polyangiitis based on kidney biopsies
8. Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression
9. Adie’s tonic pupil in primary Sjögren syndrome
10. Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study
11. Magnesium bioactive glass hybrid functionalized polyetheretherketone with immunomodulatory function to guide cell fate and bone regeneration
12. Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial
13. Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
14. Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome
15. Omics-based integrated analysis identified IKZF2 as a biomarker associated with lupus nephritis
16. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
17. CaP-based anti-inflammatory HIF-1α siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy
18. Lupus gut microbiota transplants cause autoimmunity and inflammation
19. Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
20. Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease
21. Editorial: Precision medicine and immune monitoring for infectious diseases
22. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models
23. Doigts boudines et anomalies des capillaires des replis cutanes des ongles
24. ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease
25. Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease: The FLAIR Model
26. Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
27. Bier spots associated with long COVID
28. Distinguish inverse Gottron’s papules and inverse Gottron’s sign in anti-MDA5 dermatomyositis
29. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups
30. Clinical phenotypes and prognostic factors of adult-onset Still’s disease: data from a large inpatient cohort
31. Sirt1 inhibits gouty arthritis via activating PPARγ
32. Puffy fingers and abnormal nail fold capillaries
33. Janus kinase inhibitor for multicentric reticulohistiocytosis, a new potential treatment
34. Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus
35. Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer
36. Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches
37. A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial
38. Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment
39. Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
40. Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
41. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.
42. Familial systemic lupus erythematosus associated with a loss-of-function mutation in TRPC6
43. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
44. Steroid-loaded reconstituted high-density lipoprotein nanocarrier: A new treatment for systemic lupus erythematosus
45. An Intravenous Immunoglobulin Scheme Successfully Preventing Recurrent Congenital Heart Block in Fetuses of Anti-SSA/SSB-Positive Mothers
46. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial
47. Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al
48. T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance
49. Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
50. Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.